The stock has hit a high of RS. 919 and a low of Rs. 895.
Supreme Court restrained Glenmark from manufacturing two anti-diabetes drugs, according to reports.
The stock is down 1% at Rs. 907.
The stock has hit a high of RS. 919 and a low of Rs. 895.
No comments:
Post a Comment